-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
【Pharmaceutical Network Market Analysis】On November 17, the performance of the traditional Chinese medicine sector was eye-catching, with Zhongsheng Pharmaceutical, Yiling Pharmaceutical, etc.
, and many stocks such as Wellcome Pharmaceutical, Teyi Pharmaceutical, and China Resources Sanjiu following suit
.
As of the close of trading on the 17th, the traditional Chinese medicine sector rose nearly %
.
In fact, since the rebound of the traditional Chinese medicine sector at the end of September, in less than two months from September 26 to November 17, the traditional Chinese medicine sector has risen by more than 30%.
For the reasons for the recent popularity of the traditional Chinese medicine sector, the analysis believes that it is mainly affected
by the marginal favorable industry policy.
Just recently, the National Health Commission issued a notice, clearly emphasizing the unique advantages of traditional Chinese medicine and making a reserve
of effective traditional Chinese medicine prescriptions.
Affected by this, traditional Chinese medicine-related concept stocks rose centrally, and Yiling Pharmaceutical won 4 days and 3 boards
.
On October 31, the Procurement Office of the Sanming Procurement Alliance Interprovincial Chinese Medicine (Material) Procurement Alliance issued the "Sanming Procurement Alliance Interprovincial Chinese Medicine (Material) Procurement Alliance Chinese Medicine Pieces Joint Procurement Document", from the perspective of joint procurement rules, the impact of this joint procurement on the price of drinking pieces is relatively mild and the impact on profit margin is limited
。 On October 14, the "14th Five-Year Plan" for the Development of Chinese Medicine Talents was issued, and the plan mentioned that the goal is: by 2025, the system and mechanism for the development of Chinese medicine talents that meet the characteristics of Chinese medicine will be more perfect, the training and evaluation system will be more reasonable, the scale of talents will grow rapidly, the structural layout will be more reasonable, the growth environment will be significantly optimized, and a high-quality Chinese medicine talent team will be cultivated and cultivated, and a stronger talent support
will be provided for the revitalization and development of Chinese medicine 。 In addition, in March this year, the "14th Five-Year Plan" put forward new requirements, 15 indicators reflect the high-quality development goals of Chinese medicine in the new era, and 10 key tasks specify specific measures, which clearly states that by 2025, the medical structure of traditional Chinese medicine will reach 95,000 (+31%, 2025 vs.
2020 data in parentheses); The requirement of 90% of TCM clinical departments in public general hospitals above the secondary level will continue to increase the scale of the TCM market; A number of substantive targets, such as 0.
85 beds per 1,000 population (+25%), are expected to form a positive support
for the Chinese medicine industry.
The industry believes that in recent years, the state's support policies for the traditional Chinese medicine industry have been continuously improved, from the optimization of review and approval rules, the encouragement of traditional Chinese medicine innovation and talent development, the construction of traditional Chinese medicine medical service system to medical insurance payment, etc.
, and has gradually landed from the top-level design, comprehensively promoting the rapid development of
the industry.
According to data from the Ministry of Industry and Information Technology and the National Bureau of Statistics, the overall size of China's traditional Chinese medicine market in 2021 will be more than 800 billion yuan, and under the catalyst of favorable policies, the industry expects that the industry will maintain double-digit growth during the "14th Five-Year Plan" period, and the overall market size will exceed 1 trillion yuan
.
Looking forward to the future market, securities institutions are generally optimistic about the long-term development of
the Chinese medicine industry.
For example, CITIC Securities believes that the marginal changes in epidemic prevention and control have brought investment opportunities in the vaccine sector and the traditional Chinese medicine sector, which have the attributes of consumer goods and health products, and have a long-term growth logic under the aging of the population and consumption upgrading, but the short-term growth of the sector is too high and there is a need
for adjustment.
Industrial Securities also said that the current upward trend of the pharmaceutical sector is clear, and it is recommended to actively allocate the pharmaceutical sector, and after a round of general rise, the bank believes that the performance of the subdivision will diverge
in the future.
The policies of the traditional Chinese medicine sector continue to support the development, and the favorable policies have been continuously implemented in multiple aspects and dimensions, which is expected to benefit the development of
the industry and related companies in the long run.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
to anyone.